BRCA1 and ovarian cancer: For instance, siRNAs targeting the DNA repair machinery have been used to mimic the activity of PARP inhibitors and the administration of a lipidoid-siPARP1 nanoparticle in a BRCA1-deficient ovarian cancer mouse model successfully reduced tumor growth by causing the activation of apoptosis (145).